Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 690 results for "celgene corporation headquarters"

Celgene Corporation Announces 2015 and Long-Term Financial Outlook and Preliminary 2014 Results
TeleTrader.com

Celgene Corporation to Webcast at Upcoming Investor Conferences

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (CELG) plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the ... Yahoo! UK and Ireland, 2 weeks ago
[x]  

Celgene Corporation Earns CEO Cancer Gold Standard Accreditation

(BUSINESS WIRE) -- Celgene Corporation, a global biopharmaceutical company headquartered in Summit, New Jersey, has earned the prestigious global CEO Cancer Gold Standard(TM) accreditation. This accreditation recognizes the ...
 PredictWallStreet2 months ago Celgene Earns CEO Cancer Gold Standard Accreditation  BioSpace2 months ago
[x]  
World Connector Net

ABRAXANE® Approved by European Commission for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (CELG), today announced that the European Commission (EC) has approved ABRAXANE® (paclitaxel formulated as albumin-bound ...
 Yahoo! UK and Ireland3 days ago Celgene International S??rl Release: ABRAXANE Approved By European Commission For First-Line Treatment Of Patients With Non-Small Cell Lung Cancer  BioSpace2 days ago CELGENE : ABRAXANE® Approved by European Commission for First-Line Treatment of Patients with Non-Small Cell Lung Cancer  4 Traders3 days ago ABRAXANE® Now Reimbursed in Italy as a First-Line Treatment of Adult Patients with Metastatic Pancreatic Cancer  Investor's Business Daily1 week ago
[x]  

Celgene : FORMA Therapeutics Achieves Second Major Objective in Collaboration with Celgene Corporation to Advance Innovative Protein Homeostasis Drugs

By a News Reporter-Staff News Editor at Biotech Week -- FORMA Therapeutics announced that it has successfully met a second objective under its strategic collaboration agreement with Celgene Corporation , triggering an undisclosed payment from ...
 4 Traders1 day ago FORMA Therapeutics Achieves Second Major Objective in Collaboration with Celgene Corporation to Advance Innovative Protein Homeostasis Drugs  Pettinga Financial Advisors1 week ago FORMA THERAPEUTICS : Achieves Second Major Objective in Collaboration with Celgene Corporation to Advance Innovative Protein Homeostasis Drugs  4 Traders1 week ago FORMA Therapeutics, Inc. Achieves Second Major Objective In Collaboration With Celgene To Advance Innovative Protein Homeostasis Drugs  BioSpace1 week ago
[x]  
PR Newswire

Psoriatic Arthritis Patients "pSAY YES!" to a Different Approach to Disease Management

SUMMIT, N.J. , Feb. 25, 2015 /PRNewswire/ --Celgene Corporation ( NASDAQ: CELG ), the maker of OTEZLA® (apremilast)—the first and only oral U.S. FDA-approved therapy for the treatment of adult patients with active psoriatic arthritis (PsA)— ...
 Securities Technology Monitor1 week ago CELGENE : Psoriatic Arthritis Patients "pSAY YES!" to a Different Approach to Disease Management  4 Traders1 week ago
[x]  
Proactive Investors USA

Monday Deal Review - January 12 2015

PharmaCan Capital Corp. (formerly Searchtech Ventures Inc.) (the Corporation) (TSX VENTURE:MJN) announced that subject to the completion of filings with the TSX Venture Exchange (the Exchange) it has closed its qualifying transaction (the Qualifying ...
 MENAFN1 month ago Monday Deal Review - January 26, 2015  Proactive Investors USA1 month ago Monday Deal Review - January 12, 2015  Proactive Investors USA1 month ago

Press release: 'The Corporate Reputation of Pharma in 2014 -the Patient Perspective', and how the corporate reputation of pharma companies has changed over the past four years

https://alexwyke.wordpress.com/2015/02/11/press-release-the-corporate-reputation-of-pharma-in-2014-the-patient-perspective-and-how-the-corporate-reputation-of-pharma-companies-has-changed-over-the-past-four-years/ February 11, 2015 Embargo ...
 National AIDS Treatment Advocacy Project2 weeks ago
Pharmaceutical Manufacturing Magazine

Prolong Pharmaceuticals Moves Into New Headquarters

Prolong Pharmaceuticals LLC announced the expansion of its South Plainfield, N.J., manufacturing facility. A new long-term lease on the space adjoining its current facility is adding 24,000 square feet to the existing 24,000 square feet. In ...
 Pharmaceutical Manufacturing Magazine1 month ago

Celgene : Data Presented on REVLIMID® (lenalidomide) Compared with Investigators' Choice in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Exploratory analysis in heavily pre-treated patients, in response and survival measures were reported in hard-to-treat patients Phase III ROBUST study will evaluate REVLIMID plus R-CHOP in hard-to-treat patients SAN FRANCISCO--(BUSINESS ...
 4 Traders2 months ago

Allergan CEO May Pocket $100 Million If Terminated After Buyout

February 24, 2015 By Mark Terry , BioSpace.com Breaking News Staff Irvine, Calif.-based Allergan Inc. ( AGN ) legal filings on Feb. 19 indicate that if current CEO David Pyott is terminated after the Actavis plc ( ACT ) sale, he could receive ...
 BioSpace1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - celgene corporation headquarters
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less